The Blood Cancers Today Editorial Board offers their thoughts on the past year. As we close 2023, it feels like we are all back, at full speed ahead, doing the work that draws us together and to our field. Guillermo Garcia-Manero, MD, discusses contemporary issues regarding the management of LR-MDS. This editorial outlines treatments for relapsed AML, T-Cell activation, and more. The meeting had more than 2,500 registrants attending in person or online. The practice of medicine, in many ways, can cycle like the seasons do. Karun Neupane, MD, discusses why the meeting was a valuable experience for him as a first-time attendee. September is always an exciting time for SOHO members as the month brings the Annual Meeting in Houston, Texas. The meeting will be held September 6-9, 2023, in Houston, Texas. Dr. Shadman rounds up the latest news on CLL from the summer conferences in this episode of The HemOnc Pulse. Dr. Nooka, who served as an investigator on the MagnetisMM-3 trial, discusses the impact of the accelerated approval. The Blood Cancers Today Editorial Board reflects on the latest news in the field so far in 2023. SOHO President Jennifer Brown, MD, PhD, reflects on the upcoming 11th SOHO Annual Meeting. Guillermo Garcia-Manero, MD, the 2023 SOHO President-Elect, shares his hopes and goals for the coming years. Dr. DiPersio discusses events that shaped his career, his lab’s most transformative research, and the future of transplant. We went from survival of 10% to 90% and from full-fledged chemotherapy and transplant to a chemotherapy-free regimen. Dr. Nastoupil reflects on the experiences that led her to study disparities in lymphoma and her hopes for the future. World Blood Cancer Day is marked on May 28 each year. To quote a well-known exchange from the final Harry Potter movie, “it’s complicated.” The field of hematologic oncology is now contending with reconciling the proposed rival WHO and ICC systems.